Skip to content

Accredited Cancer Centers Improve Precision Oncology Care with GenomOncology

People have a 50% chance of being diagnosed with cancer at some point in their lifetime, and this percentage continues to increase. As a result, institutions are investing in precision oncology programs to improve their patient treatment opportunities and overall survival rates.

Join GenomOncology’s Chief Technology Officer, Ian Maurer, and Director of Product Management, James Cole, PhD, for a 30-minute on-demand webinar, where we discuss:

  • The impacts, benefits, and technical requirements of a model precision oncology program.

  • How GenomOncology’s precision oncology solutions support and enhance precision oncology programs by providing clinicians access to up-to-date precision oncology information, simply integrating with institution systems, and presenting relevant data that can be efficiently and effectively utilized to improve patient outcomes.

  • The several ways numerous institutions have utilized GenomOncology to enhance their precision oncology programs in order to streamline their data enablement, improve their overall decision support, and enhance their insights and analytics to improve their overall patient cancer care.

Watch now to learn how GenomOncology can enhance your precision oncology workflows!

 

Featured Presenters

With over 20 years of software development and leadership experience, Ian leads the technical innovation at GenomOncology. Ian created GenomOncology’s Precision Oncology Platform, and continues to innovate on the platform and GO solution offerings to ensure our precision oncology solutions best serve users.

Ian Maurer0507_cropped

Ian Maurer
Chief Technology Officer


James Cole has over a decade of experience in precision oncology, making him integral in GenomOncology's understanding of the field of clinical genomics. Cole works across GenomOncology’s Precision Oncology Platform (POP), ensuring all our precision oncology solutions include the necessary precision oncology data sets in order to inform decision support and streamline patient treatment analysis and research.

James Cole, PhD

James Cole, PhD
Vice President of Product Innovation